Mineralys Therapeutics, Inc.
$20.30
-1.34 (-6.19%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -27.4%
- 3 Months
- -24.0%
- YTD
- -44.1%
- 1 Year
- -53.2%
- 3 Year annualized
- +28.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 60.1%
- Largest decline max drawdown, since Feb 2023
- -68.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.97
Own MLYS?
See how MLYS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.